The EZ-ALBI and PALBI scores contribute to the clinical application of ALBI in predicting postoperative recurrence of HCC

Abstract This research intends to assess the variance between EZ-ALBI and PALBI in forecasting recurrence following the resection of hepatocellular carcinoma (HCC). A retrospective analysis was conducted using clinical data from 522 HCC patients across two medical institutions. The study analyzed al...

Full description

Saved in:
Bibliographic Details
Main Authors: Tao Sun, Xiangkun Wang, Guangcan Zhu, Jinfu Zhang, Juan Huang, Renfeng Li, Xinguang Qiu
Format: Article
Language:English
Published: Nature Portfolio 2025-03-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-93716-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849390364716171264
author Tao Sun
Xiangkun Wang
Guangcan Zhu
Jinfu Zhang
Juan Huang
Renfeng Li
Xinguang Qiu
author_facet Tao Sun
Xiangkun Wang
Guangcan Zhu
Jinfu Zhang
Juan Huang
Renfeng Li
Xinguang Qiu
author_sort Tao Sun
collection DOAJ
description Abstract This research intends to assess the variance between EZ-ALBI and PALBI in forecasting recurrence following the resection of hepatocellular carcinoma (HCC). A retrospective analysis was conducted using clinical data from 522 HCC patients across two medical institutions. The study analyzed albumin-bilirubin values (ALBI), along with the Easy albumin-bilirubin values (EZ-ALBI) and the Platelet-albumin-bilirubin values(PALBI), while assessing the clinical traits of patients across various grades. The analysis focused on the connections between ALBI, EZ-ALBI, and PALBI, as well as their variations in predicting the recurrence of HCC following surgical procedures. Notably, the clinical characteristics of patients exhibiting varying levels of PALBI differed from those categorized under ALBI and EZ-ALBI; however, the ALBI grade shared similar characteristics with the EZ-ALBI category. A strong correlation was found between ALBI and EZ-ALBI, with a coefficient of 0.862 (95% CI: 0.838–0.882, p < 0.01), whereas ALBI and PALBI yielded a coefficient of 0.760 (95% CI: 0.838–0.882, p < 0.01). The correlation coefficient between PALBI and EZ-ALBI was recorded at 0.571 (95% CI: 0.510–0.626, p < 0.01). There was a notable difference in survival outcomes among HCC patients classified with ALBI/EZ-ALBI/PALBI grade 1 compared to those with grade 2 or 3. Additionally, Cox regression analysis identified that maximum tumor diameter (MTD), microvascular invasion (MVI), pathological grade, as well as ALBI/EZ-ALBI/PALBI grades, among other factors, were tied to a decline in progression-free survival (PFS). The area under the curve (AUC) for the ALBI model at the 1, 2, and 3-year postoperative mark was 0.705, 0.652, and 0.694, respectively. In parallel, the AUC of the EZ-ALBI model during the same time intervals was 0.708, 0.659, and 0.694, respectively. For PALBI, the AUC values recorded at 1, 2, and 3 years following surgery were 0.748, 0.707, and 0.725, respectively. ALBI, EZ-ALBI, and PALBI served as predictive indicators for the recurrence of HCC in patients after surgery. Compared to ALBI, EZ-ALBI offers greater convenience in forecasting the prognosis of HCC patients, whereas PALBI demonstrates more accuracy than ALBI in predicting their prognosis.
format Article
id doaj-art-8c8c0789d9d04f79b951e49ec6e9ff60
institution Kabale University
issn 2045-2322
language English
publishDate 2025-03-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-8c8c0789d9d04f79b951e49ec6e9ff602025-08-20T03:41:40ZengNature PortfolioScientific Reports2045-23222025-03-0115111310.1038/s41598-025-93716-9The EZ-ALBI and PALBI scores contribute to the clinical application of ALBI in predicting postoperative recurrence of HCCTao Sun0Xiangkun Wang1Guangcan Zhu2Jinfu Zhang3Juan Huang4Renfeng Li5Xinguang Qiu6Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Zhengzhou UniversityDepartment of General Surgery, Henan Provincial Hospital of Traditional Chinese Medicine (The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine)Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Thyroid Surgery, The First Affiliated Hospital of Zhengzhou UniversityAbstract This research intends to assess the variance between EZ-ALBI and PALBI in forecasting recurrence following the resection of hepatocellular carcinoma (HCC). A retrospective analysis was conducted using clinical data from 522 HCC patients across two medical institutions. The study analyzed albumin-bilirubin values (ALBI), along with the Easy albumin-bilirubin values (EZ-ALBI) and the Platelet-albumin-bilirubin values(PALBI), while assessing the clinical traits of patients across various grades. The analysis focused on the connections between ALBI, EZ-ALBI, and PALBI, as well as their variations in predicting the recurrence of HCC following surgical procedures. Notably, the clinical characteristics of patients exhibiting varying levels of PALBI differed from those categorized under ALBI and EZ-ALBI; however, the ALBI grade shared similar characteristics with the EZ-ALBI category. A strong correlation was found between ALBI and EZ-ALBI, with a coefficient of 0.862 (95% CI: 0.838–0.882, p < 0.01), whereas ALBI and PALBI yielded a coefficient of 0.760 (95% CI: 0.838–0.882, p < 0.01). The correlation coefficient between PALBI and EZ-ALBI was recorded at 0.571 (95% CI: 0.510–0.626, p < 0.01). There was a notable difference in survival outcomes among HCC patients classified with ALBI/EZ-ALBI/PALBI grade 1 compared to those with grade 2 or 3. Additionally, Cox regression analysis identified that maximum tumor diameter (MTD), microvascular invasion (MVI), pathological grade, as well as ALBI/EZ-ALBI/PALBI grades, among other factors, were tied to a decline in progression-free survival (PFS). The area under the curve (AUC) for the ALBI model at the 1, 2, and 3-year postoperative mark was 0.705, 0.652, and 0.694, respectively. In parallel, the AUC of the EZ-ALBI model during the same time intervals was 0.708, 0.659, and 0.694, respectively. For PALBI, the AUC values recorded at 1, 2, and 3 years following surgery were 0.748, 0.707, and 0.725, respectively. ALBI, EZ-ALBI, and PALBI served as predictive indicators for the recurrence of HCC in patients after surgery. Compared to ALBI, EZ-ALBI offers greater convenience in forecasting the prognosis of HCC patients, whereas PALBI demonstrates more accuracy than ALBI in predicting their prognosis.https://doi.org/10.1038/s41598-025-93716-9ALBIEZ-ALBIPALBIHepatocellular carcinomaPostoperative recurrence
spellingShingle Tao Sun
Xiangkun Wang
Guangcan Zhu
Jinfu Zhang
Juan Huang
Renfeng Li
Xinguang Qiu
The EZ-ALBI and PALBI scores contribute to the clinical application of ALBI in predicting postoperative recurrence of HCC
Scientific Reports
ALBI
EZ-ALBI
PALBI
Hepatocellular carcinoma
Postoperative recurrence
title The EZ-ALBI and PALBI scores contribute to the clinical application of ALBI in predicting postoperative recurrence of HCC
title_full The EZ-ALBI and PALBI scores contribute to the clinical application of ALBI in predicting postoperative recurrence of HCC
title_fullStr The EZ-ALBI and PALBI scores contribute to the clinical application of ALBI in predicting postoperative recurrence of HCC
title_full_unstemmed The EZ-ALBI and PALBI scores contribute to the clinical application of ALBI in predicting postoperative recurrence of HCC
title_short The EZ-ALBI and PALBI scores contribute to the clinical application of ALBI in predicting postoperative recurrence of HCC
title_sort ez albi and palbi scores contribute to the clinical application of albi in predicting postoperative recurrence of hcc
topic ALBI
EZ-ALBI
PALBI
Hepatocellular carcinoma
Postoperative recurrence
url https://doi.org/10.1038/s41598-025-93716-9
work_keys_str_mv AT taosun theezalbiandpalbiscorescontributetotheclinicalapplicationofalbiinpredictingpostoperativerecurrenceofhcc
AT xiangkunwang theezalbiandpalbiscorescontributetotheclinicalapplicationofalbiinpredictingpostoperativerecurrenceofhcc
AT guangcanzhu theezalbiandpalbiscorescontributetotheclinicalapplicationofalbiinpredictingpostoperativerecurrenceofhcc
AT jinfuzhang theezalbiandpalbiscorescontributetotheclinicalapplicationofalbiinpredictingpostoperativerecurrenceofhcc
AT juanhuang theezalbiandpalbiscorescontributetotheclinicalapplicationofalbiinpredictingpostoperativerecurrenceofhcc
AT renfengli theezalbiandpalbiscorescontributetotheclinicalapplicationofalbiinpredictingpostoperativerecurrenceofhcc
AT xinguangqiu theezalbiandpalbiscorescontributetotheclinicalapplicationofalbiinpredictingpostoperativerecurrenceofhcc
AT taosun ezalbiandpalbiscorescontributetotheclinicalapplicationofalbiinpredictingpostoperativerecurrenceofhcc
AT xiangkunwang ezalbiandpalbiscorescontributetotheclinicalapplicationofalbiinpredictingpostoperativerecurrenceofhcc
AT guangcanzhu ezalbiandpalbiscorescontributetotheclinicalapplicationofalbiinpredictingpostoperativerecurrenceofhcc
AT jinfuzhang ezalbiandpalbiscorescontributetotheclinicalapplicationofalbiinpredictingpostoperativerecurrenceofhcc
AT juanhuang ezalbiandpalbiscorescontributetotheclinicalapplicationofalbiinpredictingpostoperativerecurrenceofhcc
AT renfengli ezalbiandpalbiscorescontributetotheclinicalapplicationofalbiinpredictingpostoperativerecurrenceofhcc
AT xinguangqiu ezalbiandpalbiscorescontributetotheclinicalapplicationofalbiinpredictingpostoperativerecurrenceofhcc